Chimerism in lymphoid tissues and donor-specific antibody response after injection of allogenic splenic dendritic cells from Fischer rats to Lewis recipients.
The aim of this work was to study cellular chimerism achieved in lymphoid tissues and production of antidonor lymphocyte antibodies after injection of splenic dendritic cells (DCs) from Fischer F344 rats to Lewis recipients, a model of chronic rejection. DCs isolated from the spleen expressed OX62 (95%), CD80 (70%), and CD86 (80%). Two doses of these nonplasmacytoid splenic DCs from Fischer rats (2 x 10(6) and 5 x 10(6)), which had been labeled ex vivo with a TRITC fluorochrome (PKH26), were injected to Lewis recipients. Using fluorescence microscopy TRITC positive cells were localized at day 15 and day 45 in frozen sections from spleen, thymus, mesenteric lymph nodes, heart, liver, kidney, and skin (n = 5 per group). Donor-specific antibodies were sought with flow cytometric crossmatches in serum samples taken at 7, 15, 30, and 45 days. TRITC-positive DCs were essentially localized in the spleen, the thymus, and lymph nodes of Lewis recipients. The majority of DCs were detected in the spleen (14.9 +/- 3.3 and 14.3 +/- 0.9 DCs/per high power field respectively at day 45). A significant number of DCs was also detected in the thymus and mesenteric lymph nodes at both times. Only some scattered TRITC-positive cells were observed in other organs. The number of DCs was stable over time and did not depend on the injected dose. A positive flow cytometric cross-match was observed at day 30 in all recipients independent of the injected dose. These data showed that 2 x 10(6) mature, nonplasmocytoid DCs from F344 rats injected to Lewis recipients induced stable chimerism in primary and secondary lymphoid organs and a humoral response to donor antigens.
Bocrie
O
O
UPRES EA 563, Department of Pathology, Faculty of Medicine, 7 boulevard Jeanne d'Arc, 21079 Dijon Cedex, France.
Abdelouhab
K
K
Martin
L
L
Guignier
F
F
Mousson
C
C
Rifle
G
G
D000818:Animals; D000917:Antibody Formation; D015703:Antigens, CD / Q000032:analysis; D015214:Antigens, Differentiation, Myelomonocytic / Q000032:analysis; D018122:B7-1 Antigen / Q000032:analysis; D003713:Dendritic Cells / Q000637:transplantation*; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000276:immunology*; D007202:Indicators and Reagents; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D012235:Rhodamines; D013154:Spleen / Q000276:immunology*; D018183:Transplantation Chimera / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology*; D000097382:CD68 Molecule
D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D018122:B7-1 Antigen; D007202:Indicators and Reagents; D012235:Rhodamines; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C009434:tetramethylrhodamine isothiocyanate